Listing #7851333 oncnursingnews.com
448
oncnursingnews.com
More Listing
The FDA granted a priority review for a Biologics License Application (BLA) to
bastilimab for the treatment of recurrent or metastatic cervical cancer. Cancer ...
Category
Website Performance
| observedTraceEndTs | 4213438026980 |
| observedLargestContentfulPaint | 1.34 Sec |
| observedFirstMeaningfulPaint | 1.34 Sec |
| observedLargestContentfulPaintAllFrames | 1.34 Sec |
| observedFirstContentfulPaint | 0.33 Sec |
| observedLargestContentfulPaintAllFramesTs | 4213430979227 |
| interactive | 7.27 Sec |
| observedTimeOrigin | 0 Sec |
| observedLastVisualChange | 6.01 Sec |
| cumulativeLayoutShift | 0 Sec |
| firstContentfulPaint | 1.39 Sec |
| speedIndex | 3.83 Sec |
| firstMeaningfulPaint | 2.19 Sec |
| observedSpeedIndex | 2.73 Sec |
| observedLoadTs | 4213432221026 |
| observedFirstPaintTs | 4213429977528 |
| observedFirstPaint | 0.33 Sec |
| observedDomContentLoaded | 0.18 Sec |
| cumulativeLayoutShiftMainFrame | 0 Sec |
| observedDomContentLoadedTs | 4213429820005 |
| observedFirstContentfulPaintTs | 4213429977528 |
| observedTimeOriginTs | 4213429643339 |
| observedLastVisualChangeTs | 4213435655339 |
| observedFirstVisualChange | 0.31 Sec |
| observedNavigationStart | 0 Sec |
| totalCumulativeLayoutShift | 0 Sec |
| totalBlockingTime | 0.65 Sec |
| observedLargestContentfulPaintTs | 4213430979227 |
| observedTotalCumulativeLayoutShift | 0 Sec |
| observedFirstContentfulPaintAllFramesTs | 4213429977528 |
| observedCumulativeLayoutShiftMainFrame | 0 Sec |
| observedTraceEnd | 8.38 Sec |
| maxPotentialFID | 0.25 Sec |
| observedFirstContentfulPaintAllFrames | 0.33 Sec |
| observedFirstMeaningfulPaintTs | 4213430979227 |
| observedCumulativeLayoutShift | 0 Sec |
| observedSpeedIndexTs | 4213432375297 |
| largestContentfulPaint | 5.16 Sec |
| observedLoad | 2.58 Sec |
| observedNavigationStartTs | 4213429643339 |
| observedFirstVisualChangeTs | 4213429955339 |
